|
1
|
Kelley JR and Duggan JM: Gastric cancer
epidemiology and risk factors. J Clin Epidemiol. 56:1–9. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society. Colorectal cancer
facts and figures. 2005
|
|
3
|
Moch H, Schraml P, Bubendorf L, Mirlacher
M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP and Sauter G:
High-throughput tissue microarray analysis to evaluate genes
uncovered by cDNA microarray screening in renal cell carcinoma. Am
J Pathol. 154:981–986. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumada T, Tsuneyama K, Hatta H, Ishizawa S
and Takano Y: Improved 1-h rapid immunostaining method using
intermittent microwave irradiation: practicability based on 5 years
application in Toyama Medical and Pharmaceutical University
Hospital. Mod Pathol. 17:1141–1149. 2004.
|
|
5
|
Zheng H, Tsuneyama K, Cheng C, Takahashi
H, Cui Z, Murai Y, Nomoto K and Takano Y: An immunohistochemical
study of P53 and Ki-67 in gastrointestinal adenoma and
adenocarcinoma using tissue microarray. Anticancer Res.
26:2353–2360. 2006.PubMed/NCBI
|
|
6
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Tsuneyama K and Takano Y: Low expression of FHIT and PTEN
correlates with malignancy of gastric carcinomas: tissue-array
findings. Appl Immunohistochem Mol Morphol. 15:432–440. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li XH, Zheng HC, Takahashi H, Masuda S,
Yang XH and Takano Y: PTEN expression and mutation in colorectal
carcinomas. Oncol Rep. 22:757–764. 2009.PubMed/NCBI
|
|
8
|
Xing YN, Yang X, Xu XY, Zheng Y, Xu HM,
Takano Y and Zheng HC: The altered expression of ING5 protein is
involved in gastric carcinogenesis and subsequent progression. Hum
Pathol. 42:25–35. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng HC, Xia P, Xu XY, Takahashi H and
Takano Y: The nuclear to cytoplasmic shift of ING5 protein during
colorectal carcinogenesis with their distinct links to pathologic
behaviors of carcinomas. Hum Pathol. 42:424–433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng HC, Takahashi H, Li XH, Hara T,
Masuda S, Guan YF and Takano Y: Downregulated parafibromin
expression is a promising marker for pathogenesis, invasion,
metastasis and prognosis of gastric carcinomas. Virchows Arch.
452:147–155. 2008. View Article : Google Scholar
|
|
11
|
Zheng HC, Wei ZL, Xu XY, Nie XC, Yang X,
Takahashi H and Takano Y: Parafibromin expression is an independent
prognostic factor for colorectal carcinomas. Hum Pathol.
8:1089–1102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JH, Park SR, Chay KO, Seo YW, Kook H,
Ahn KY, Kim YJ and Kim KK: KAI1 COOH-terminal interacting
tetraspanin (KITENIN), a member of the tetraspanin family,
interacts with KAI1, a tumour metastasis suppressor, and enhances
metastasis of cancer. Cancer Res. 64:4235–4243. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schoenfeld N, Bauer MK and Grimm S: The
metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through
reactive oxygen intermediates. FASEB J. 18:158–160. 2004.PubMed/NCBI
|
|
14
|
Zheng H, Tsuneyama K, Cheng C, Takahashi
H, Cui Z, Nomoto K, Murai Y and Takano Y: Expression of KAI1 and
tenascin, and microvessel density are closely correlated with liver
metastasis of gastrointestinal adenocarcinoma. J Clin Pathol.
60:50–56. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maass N, Hojo T, Ueding M, Luttges J,
Kloppel G, Jonat W and Nagasaki K: Expression of the tumor
suppressor gene Maspin in human pancreatic cancers. Clin Cancer
Res. 7:812–817. 2001.PubMed/NCBI
|
|
16
|
Sood AK, Fletcher MS, Gruman LM, Coffin
JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix
MJ: The paradoxical expression of maspin in ovarian carcinoma. Clin
Cancer Res. 8:2924–2932. 2002.PubMed/NCBI
|
|
17
|
Hirai K, Koizumi K, Haraguchi S, Hirata T,
Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K
and Kawamoto M: Prognostic significance of the tumor suppressor
gene maspin in non-small cell lung cancer. Ann Thorac Surg.
79:248–253. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ito Y, Yoshida H, Tomoda C, Uruno T,
Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kuma K
and Miyauchi A: Maspin expression is directly associated with
biological aggressiveness of thyroid carcinoma. Thyroid. 14:13–18.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sugimoto S, Maass N, Takimoto Y, Sato K,
Minei S, Zhang M, Hoshikawa Y, Junemann KP, Jonat W and Nagasaki K:
Expression and regulation of tumor suppressor gene maspin in human
bladder cancer. Cancer Lett. 203:209–215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu M, Zheng H, Tsuneyama K, Takahashi H,
Nomoto K, Xu H and Takano Y: Paradoxical expression of maspin in
gastric carcinomas: correlation with carcinogenesis and
progression. Hum Pathol. 38:1248–1255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng H, Tsuneyama K, Cheng C, Takahashi
H, Cui Z, Murai Y, Nomoto K and Takano Y: Maspin expression was
involved in colorectal adenoma-adenocarcinoma sequence and liver
metastasis of tumors. Anticancer Res. 27:259–265. 2007.PubMed/NCBI
|
|
22
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Niwa H, Tsuneyama K and Takano Y: Expressions of MMP-2,
MMP-9 and VEGF are closely linked to growth, invasion, metastasis
and angiogenesis of gastric carcinoma. Anticancer Res.
26:3579–3583. 2006.PubMed/NCBI
|
|
23
|
Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC
and Xin Y: Role of PTEN and MMP-7 expression in growth, invasion,
metastasis and angiogenesis of gastric carcinoma. Pathol Int.
53:659–666. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng HC, Wang W, Xu XY, Xia P, Yu M,
Sugiyama T and Takano Y: Up-regulated EMMPRIN/CD147 protein
expression might play a role in colorectal carcinogenesis and its
subsequent progression without an alteration of its glycosylation
and mRNA level. J Cancer Res Clin Oncol. 137:585–596. 2011.
View Article : Google Scholar
|
|
25
|
Zheng HC, Takahashi H, Murai Y, Cui ZG,
Nomoto K, Miwa S, Tsuneyama K and Takano Y: Upregulated
EMMPRIN/CD147 might contribute to growth and angiogenesis of
gastric carcinoma: a good marker for local invasion and prognosis.
Br J Cancer. 95:1371–1378. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Zheng H, Hara T, Takahashi H, Masuda
S, Wang Z, Yang X, Guan Y and Takano Y: Aberrant expression of
cortactin and fascin are effective markers for pathogenesis,
invasion, metastasis and prognosis of gastric carcinomas. Int J
Oncol. 33:69–79. 2008.PubMed/NCBI
|
|
27
|
Zheng HC, Zheng YS, Li XH, Takahashi H,
Hara T, Masuda S, Yang XH, Guan YF and Takano Y: Arp2/3
overexpression contributed to pathogenesis, growth and invasion of
gastric carcinoma. Anticancer Res. 28:2225–2232. 2008.PubMed/NCBI
|
|
28
|
Takahashi H, Wang JP, Zheng HC, Masuda S
and Takano Y: Overexpression of GRP78 and GRP94 is involved in
colorectal carcinogenesis. Histol Histopathol. 26:663–671.
2011.PubMed/NCBI
|
|
29
|
Zheng HC, Takahashi H, Li XH, Hara T,
Masuda S, Guan YF and Takano Y: Overexpression of GRP78 and GRP94
are markers for aggressive behavior and poor prognosis in gastric
carcinomas. Hum Pathol. 39:1042–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng HC, Xu XY, Xia P, Yu M, Takahashi H
and Takano Y: Involvement of inactive GSK3beta overexpression in
tumorigenesis and progression of gastric carcinomas. Hum Pathol.
41:1255–1264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng HC, Tsuneyama K, Takahashi H, Miwa
S, Sugiyama T, Popivanova BK, Fujii C, Nomoto K, Mukaida N and
Takano Y: Aberrant Pim-3 expression is involved in gastric adenoma
adenocarcinoma sequence and cancer progression. J Cancer Res Clin
Oncol. 134:481–488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li XH, Zheng HC, Wang ZG, Takahashi H,
Yang XH, Guan YF and Takano Y: The clinicopathological and
prognostic significance of MUC-1 expression in Japanese gastric
carcinomas: an immunohistochemical study of tissue microarrays.
Anticancer Res. 28:1061–1067. 2008.PubMed/NCBI
|
|
33
|
Zheng H, Takahashi H, Nakajima T, Murai Y,
Cui Z, Nomoto K, Tsuneyama K and Takano Y: MUC6 down-regulation
correlates with gastric carcinoma progression and a poor prognosis:
an immunohistochemical study with tissue microarrays. J Cancer Res
Clin Oncol. 132:817–823. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng HC, Xu XY, Yu M, Takahashi H, Masuda
S and Takano Y: The role of Reg IV gene and its encoding product in
gastric carcinogenesis. Hum Pathol. 41:59–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng HC, Sugawara A, Okamoto H, Takasawa
S, Takahashi H, Masuda S and Takano Y: Expression profile of the
REG gene family in colorectal carcinoma. J Histochem Cytochem.
59:106–115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Miwa S, Tsuneyama K and Takano Y: Pathobiological
characteristics of intestinal and diffuse-type gastric carcinoma in
Japan: an immunostaining study on the tissue microarray. J Clin
Pathol. 60:273–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng HC, Li XH, Hara T, Masuda S, Yang
XH, Guan YF and Takano Y: Mixed-type gastric carcinomas exhibit
more aggressive features and indicate the histogenesis of
carcinomas. Virchows Arch. 452:525–534. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zheng HC, Zheng YS, Xia P, Xu XY, Xing YN,
Takahashi H, Guan YF and Takano Y: The pathobiological behaviors
and prognosis associated with Japanese gastric adenocarcinomas of
pure WHO histological subtypes. Histol Histopathol. 25:445–452.
2010.PubMed/NCBI
|
